Oric Pharmaceuticals Inc (ORIC) returns
Oric Pharmaceuticals returns over 5 years
$1,000 invested in Oric Pharmaceuticals five years ago was worth $631.15 at the close on October 30, 2026, with dividends reinvested: an average return of -8.8% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -31.4% | — | $685.97 | -0.9% |
| 3 months | -20.6% | — | $793.81 | +2.1% |
| Year to date | +13.0% | — | $1,130 | +11.7% |
| 1 year | -30.7% | — | $692.65 | +12.4% |
| 3 years | +45.1% | +13.2% | $1,451 | +88.5% |
| 5 years | -36.9% | -8.8% | $631.15 | +76.0% |
Oric Pharmaceuticals return by calendar year
| Year | ORIC | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +13.0% | +11.7% | +1.3% |
| 2025 | +1.4% | +17.7% | -16.4% |
| 2024 | -12.3% | +24.9% | -37.2% |
| 2023 | +56.2% | +26.2% | +30.0% |
| 2022 | -59.9% | -18.2% | -41.8% |
| 2021 | -56.6% | +28.7% | -85.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Oric Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.